Induction of EMT confers resistance of NSCLC cells to EGFR-tyrosine kinase inhibitors; however, it may be re-sensitized by enforced inhibition of other pathways e.g., the Hedgehog pathway [73]. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.